Variability of treatment duration for bacteraemia in the critically ill: A multinational survey

Alberto Corona, Guido Bertolini, Anna Maria Ricotta, A. J Peter Wilson, Mervyn Singer

Research output: Contribution to journalArticlepeer-review


Objectives: No definitive evidence is available to inform 'best' antibiotic practice for treating bacteraemia in the critically ill patient, either in terms of duration of therapy, or the use of mono- versus combination therapy. We therefore undertook a large-scale international survey to assess the variability of current practice. Methods: A questionnaire was sent to membership lists of national and international intensive care societies. Results: Responses from 254 intensive care units in 34 countries revealed a wide variation in antibiotic strategy for all types of bacteraemia, ranging from short course (≤5 days) therapy with restricted-spectrum antibiotics, to long course (≥10 days) use of broad-spectrum combinations. Two factors were significantly associated with antibiotic prescribing practice, namely the country of origin (in those with ≥10 responders) and the level of microbiologist and/or infectious diseases specialist input. The greater the specialist input, the shorter the duration of therapy (P

Original languageEnglish
Pages (from-to)849-852
Number of pages4
JournalJournal of Antimicrobial Chemotherapy
Issue number5
Publication statusPublished - Nov 2003


  • Antibiotics
  • Infections
  • Intensive care
  • Sepsis

ASJC Scopus subject areas

  • Pharmacology
  • Microbiology


Dive into the research topics of 'Variability of treatment duration for bacteraemia in the critically ill: A multinational survey'. Together they form a unique fingerprint.

Cite this